Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (161-170 of 447) with videos related to

Pageof 45
Sort By:
Nature Communications|June 19, 2021
Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cellsPatrick D Rädler, Barbara L Wehde, Aleata A Triplett, et al.
Breast Cancer Research : BCR|January 22, 2021
PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumorsFeng Bai, Shiqin Liu, Xiong Liu, et al.
Breast Cancer Research : BCR|March 2, 2019
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumoursArian Lundberg, Linda S Lindström, Jingmei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancerAleix Prat, Maggie Chon U Cheang, Miguel Martín, et al.
Cell Cycle (Georgetown, Tex.)|April 20, 2011
RB1 and p53 at the crossroad of EMT and triple-negative breast cancerZhe Jiang, Robert Jones, Jeff C Liu, et al.
Plos One|April 3, 2010
SWISS MADE: Standardized WithIn Class Sum of Squares to evaluate methodologies and dataset elementsChristopher R Cabanski, Yuan Qi, Xiaoying Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsArian Lundberg, Linda S Lindström, J Chuck Harrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Activation of host wound responses in breast cancer microenvironmentMelissa A Troester, Myung Hee Lee, Matthew Carter, et al.
The Journal of Clinical Investigation|August 4, 2010
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 statusZhe Jiang, Tao Deng, Robert Jones, et al.
Cancer|April 8, 2011
The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastasesCarey K Anders, Allison M Deal, C Ryan Miller, et al.
Pageof 45

Showing results (161-170 of 447) with videos related to

Sort By:
Pageof 45
Nature Communications|June 19, 2021
Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cellsPatrick D Rädler, Barbara L Wehde, Aleata A Triplett, et al.
Breast Cancer Research : BCR|January 22, 2021
PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumorsFeng Bai, Shiqin Liu, Xiong Liu, et al.
Breast Cancer Research : BCR|March 2, 2019
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumoursArian Lundberg, Linda S Lindström, Jingmei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancerAleix Prat, Maggie Chon U Cheang, Miguel Martín, et al.
Cell Cycle (Georgetown, Tex.)|April 20, 2011
RB1 and p53 at the crossroad of EMT and triple-negative breast cancerZhe Jiang, Robert Jones, Jeff C Liu, et al.
Plos One|April 3, 2010
SWISS MADE: Standardized WithIn Class Sum of Squares to evaluate methodologies and dataset elementsChristopher R Cabanski, Yuan Qi, Xiaoying Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer CohortsArian Lundberg, Linda S Lindström, J Chuck Harrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Activation of host wound responses in breast cancer microenvironmentMelissa A Troester, Myung Hee Lee, Matthew Carter, et al.
The Journal of Clinical Investigation|August 4, 2010
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 statusZhe Jiang, Tao Deng, Robert Jones, et al.
Cancer|April 8, 2011
The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastasesCarey K Anders, Allison M Deal, C Ryan Miller, et al.
Pageof 45